TherapeuticsMD Inc. to Present at Upcoming Investor Conferences

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced CEO Robert G. Finizio will present an overview of the company at the following investor conferences:

• 40th Annual Deutsche Bank Securities Health Care Conference in Boston, Thursday, May 7 at 11:20 a.m. EDT at the InterContinental Boston Hotel.
• Bank of America Merrill Lynch 2015 Health Care Conference, Wednesday, May 13 at 11:20 a.m. PDT at the Encore at the Wynn in Las Vegas.

To listen to the live audio webcast of the presentations during the sessions, please visit the company's website, www.therapeuticsmd.com, and click the “Investor” tab. Replays of each webcast will be available for 30 days after the initial presentation.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its patented SYMBODA™ technology platform, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes two phase 3 products. The company also manufactures and distributes branded and generic prescription prenatal vitamins as well as over-the-counter vitamins under the vitaMedMD® and BocaGreenMD® brands. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com and www.bocagreenmd.com.